Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, indicating a minor update. No changes to study details, eligibility criteria, or locations.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a minor revision update: v3.4.1 was added and v3.4.0 was removed, with no visible changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and updated minor metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act data) and the revision tag to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3; this minor housekeeping update does not affect trial content or participation details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA dedicated Locations section has been added, listing New York and Texas sites, while the old 'New York Locations' and 'Texas Locations' labels were removed.SummaryDifference0.3%

- Check91 days agoChange DetectedPublication section text updated to indicate PubMed publications are auto-filled and may not relate to the study. The page revision note was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.